MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Catalyst Pharmaceutical Partners Company Profile (NASDAQ:CPRX)

Consensus Ratings for Catalyst Pharmaceutical Partners (NASDAQ:CPRX) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $6.06 (900.25% upside)

Analysts' Ratings History for Catalyst Pharmaceutical Partners (NASDAQ:CPRX)
Show:
DateFirmActionRatingPrice TargetActions
4/26/2016Piper JaffrayDowngradeOverweight -> Neutral$6.00 -> $1.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/22/2016Roth CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/20/2016SunTrustReiterated RatingBuy$7.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2015MLV & Co.Initiated CoverageBuy$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/1/2014AegisBoost Price TargetPositive$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/15/2014HC WainwrightBoost Price TargetPositive -> Buy$5.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/26/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha